Fritextsökning
Artiklar per år
Innehållstyper
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell division in several cancers.
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into the research of analyzing markers in body fluids.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established regulations stating that pharmaceuticals must be tested for children as well as for adults.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Metabolic pro heads prefect post
The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Travelling scholarship to DTU professor
The Vera og Carl Johan Michaelsens Rejselegat has the founder of the Medicine and Technology program at DTU with a scholarship.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Lund honours milieu enthusiast
Four professors at the University of Lund has appointed the milieu chief of the university as honorary doctor.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
Martin Bergö: "The Idea is the Thing"
researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
BREAKING